Fischer Medical Ventures Reports 123% YoY Surge in Total Income for Q2 FY26

Fischer Medical Ventures Ltd, a leading company in medical imaging and advanced diagnostics, has announced a 123% YoY surge in total income for Q2 FY26. The company's EBITDA margin stands at 21.10%, with a net profit of 13.96%. The surge in profitability reflects the scalability of the company's model, better product realization, and the growing acceptance of Fischer's technology across India and overseas markets. The company is well-aligned with the trends in India's MedTech and diagnostic industry, leveraging its expertise in MRI systems, AI diagnostics, and digital health platforms.